课题基金 / 基金详情

An Assay System for Cancer Gene Discovery

An Assay System for Cancer Gene Discovery
癌症基因发现的检测系统
批准号:
7163228
负责人:
MARK S. CHEE
金额:
$9.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2007-02-28

项目摘要

项目成果

MARK S. CHEE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aim of this project is to develop an innovative, highly efficient assay for detecting genes that may be functionally important in cancer. There are a number of challenges to detecting such genes, including the extensive mutation and rearrangement of the cancer genome; the variety of molecular mechanisms which can go awry, leading to extensive molecular variation between cancers; and the heterogeneity of cancer samples, which tend to include a mixture of cell types, both normal and abnormal. Our strategy for detecting cancer causing genes is to apply microarray concepts to enable a high-throughput genome-wide screening approach that will help overcome some of the challenges due to molecular and cellular heterogeneity. In the first phase of the project, we intend to develop a simple model system for assay development by constructing plasmid clones and using synthetic oligonucleotides specific for a small number of genes. In Phase II, we will expand the assay system to include a large set of genes, and we will validate the assay system using actual cancer samples and controls. We expect that, once developed, our approach will allow many samples to be screened at a high resolution, rapidly, reliably and cost- effectively. Our approach may enable the discovery of new genes that play an important role in cancer. Some genes that help transform normal cells into cancerous ones have proven to be good targets for the development of more effective cancer drugs. However, much remains to be discovered about such genes and the mechanisms by which they act. This proposal is aimed at developing a powerful and efficient new way to find important cancer genes, which may lead to a better understanding of the disease and improved tests and treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed Assays for Improving Rheumatoid Arthritis Diagnostics
  • 批准号:
    8833870
  • 项目类别:
  • 资助金额:
    $22.47万
  • 财政年份:
    2014
  • 负责人:
    MARK S. CHEE
  • 依托单位:
Multiplexed Protein Assays
  • 批准号:
    8648596
  • 项目类别:
  • 资助金额:
    $35.0万
  • 财政年份:
    2014
  • 负责人:
    MARK S. CHEE
  • 依托单位:
A High Throughput Assay for MHC-Peptide Interactions
  • 批准号:
    8593060
  • 项目类别:
  • 资助金额:
    $22.38万
  • 财政年份:
    2013
  • 负责人:
    MARK S. CHEE
  • 依托单位:
Structurally Diverse Encoded Peptide Sets
  • 批准号:
    8669019
  • 项目类别:
  • 资助金额:
    $33.46万
  • 财政年份:
    2013
  • 负责人:
    MARK S. CHEE
  • 依托单位:
国内基金
海外基金
雷特综合症致病蛋白MeCP2在DNA损伤修复中的功能及分子机制研究
  • 批准号:
    32070780
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    刘红美
  • 依托单位:
组蛋白去乙酰化酶SirT7翻译后修饰及其在调控肿瘤耐药中的作用研究
  • 批准号:
    32070770
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    孙莲慧
  • 依托单位:
新的FANCM关联蛋白复合物FMAP150-FMAP160调控FANCM修复停滞复制叉的作用及机制
  • 批准号:
    32070716
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    ZHIJIANG YAN
  • 依托单位:
激活SENP1-Sirt3轴改善线粒体健康对延缓衰老的作用与机制研究
  • 批准号:
    92049113
  • 项目类别:
    重大研究计划
  • 资助金额:
    60.0万元
  • 批准年份:
    2020
  • 负责人:
    王田实
  • 依托单位: